Overview of nuclides for bone pain palliation
- 1 April 1998
- journal article
- review article
- Published by Elsevier in Applied Radiation and Isotopes
- Vol. 49 (4) , 277-283
- https://doi.org/10.1016/s0969-8043(97)00039-0
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- A comparison of the palliative effects of strontium-89 and external beam radiotherapy in metastatic prostate cancerRadiotherapy and Oncology, 1994
- Strontium 89 Therapy and Relief of Pain in Patients with Prostatic Carcinoma Metastatic to BoneAmerican Journal of Clinical Oncology, 1993
- Results of a randomized phase-III trial to evaluate the efficacy of strontium-89 adjuvant to local field external beam irradiation in the management of endocrine resistant metastatic prostate cancerInternational Journal of Radiation Oncology*Biology*Physics, 1993
- Biodistribution of Sn-117m(4+)DTPA for palliative therapy of painful osseous metastases.Radiology, 1993
- 89Strontium in bone metastases from hormone resistant prostate cancer: palliation effect and biochemical changesBritish Journal of Cancer, 1992
- Strontium-89 chloride for pain palliation in prostatic skeletal malignancyThe British Journal of Radiology, 1991
- Strontium-89: treatment results and kinetics in patients with painful metastatic prostate and breast cancer in bone.RadioGraphics, 1989
- The development and in-vivo behavior of tin containing radiopharmaceuticals—I. Chemistry, preparation, and biodistribution in small animalsInternational Journal of Nuclear Medicine and Biology, 1985
- Results of 89 Strontium Therapy in Patients with Carcinoma of the Prostate and Incurable Pain from Bone Metastases: A Preliminary ReportJournal of Urology, 1976